Olanzapine‐Based Triple Regimens Versus Neurokinin‐1 Receptor Antagonist‐Based Triple Regimens in Preventing Chemotherapy‐Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta‐Analysis

BACKGROUND. The current antiemetic prophylaxis for patients treated with highly emetogenic chemotherapy (HEC) included the olanzapine‐based triplet and neurokinin‐1 receptor antagonists (NK‐1RAs)‐based triplet. However, which one shows better antiemetic effect remained unclear. MATERIALS AND METHODS...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Zhang, Zhonghan, Zhang, Yaxiong, Chen, Gang, Hong, Shaodong, Yang, Yunpeng, Fang, Wenfeng, Luo, Fan, Chen, Xi, Ma, Yuxiang, Zhao, Yuanyuan, Zhan, Jianhua, Xue, Cong, Hou, Xue, Zhou, Ting, Ma, Shuxiang, Gao, Fangfang, Huang, Yan, Chen, Likun, Zhou, Ningning, Zhao, Hongyun, Zhang, Li
Format: Artigo
Idioma:Inglês
Publicat: AlphaMed Press 2018
Matèries:
Symptom Management and Supportive Care
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5947448/
https://ncbi.nlm.nih.gov/pubmed/29330211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0378
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars